Pharmacogenomics

Epigenomics at the tipping point
pp. 1781-1783(3)
Authors: Stamatoyannopoulos, John A; Dunham, Ian

Pharmacoepigenetics and pharmacoepigenomics
pp. 1785-1786(2)
Author: Peedicayil, Jacob

News & Views in Pharmacogenomics
pp. 1787-1789(3)

Interview
pp. 1791-1795(5)
Author: Jirtle, Randy L

Research Highlights
pp. 1797-1799(3)
Authors: Connolly, Roisin M; Visvanathan, Kala

Correlation between MDR1 methylation status in the promoter region and MDR1 genetic polymorphism in 194 healthy Chinese Han subjects
pp. 1801-1808(8)
Authors: Jiang, Zhi-Ping; Xu, Ping; Liu, Rong-Rong; Li, Huan-De; Wang, Guan-Ping; Zhao, Xie-Lan; Chen, Fan-Ping

Epigenetic and pharmacoepigenomic studies of major psychoses and potentials for therapeutics
pp. 1809-1823(15)
Authors: Abdolmaleky, Hamid Mostafavi; Zhou, Jin-Rong; Thiagalingam, Sam; Smith, Cassandra L

Pharmaco(epi)genomics in ovarian cancer
pp. 1825-1834(10)
Authors: Paige, Adam JW; Brown, Robert

Epigenetics and dermatological disease
pp. 1835-1850(16)
Author: Millington, George WM

Epigenetics and obesity
pp. 1851-1860(10)
Authors: Stööger, Reinhard

Germline epimutation in humans
pp. 1861-1868(8)
Authors: Cropley, Jennifer E; Martin, David IK; Suter, Catherine M

Emerging methods for analysis of the cancer methylome
pp. 1869-1878(10)
Authors: Chang, Jer-Wei; Huang, Tim Hui-Ming; Wang, Yi-Ching

Epigenomics and breast cancer
pp. 1879-1902(24)
Authors: Lo, Pang-Kuo; Sukumar, Saraswati

Pharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment response
pp. 1903-1916(14)
Authors: Smits, Kim M; Cleven, Arjen HG; Weijenberg, Matty P; Hughes, Laura AE; Herman, James G; de Bruïïne, Adriaan P; van Engeland, Manon

DNA methylation and cancer pathways in gastrointestinal tumors
pp. 1917-1928(12)
Authors: Suzuki, Hiromu; Tokino, Takashi; Shinomura, Yasuhisa; Imai, Kohzoh; Toyota, Minoru

Acknowledgements
pp. 1945-1945(1)